A specialist periodical report : Amino acids, peptides and proteins / editors: Maxim Ryadnov (National Physical Laboratory, UK), Ferenc Hudecz (Eötvös Lorand University, Hungary)
Cover; Preface; Contents; A short guide to abbreviations and their use in peptide science; Search and destroy: versatile proteins offer unique structural solutions against uracil in DNA; 1 The widening chemical space of DNA; 2 Uracil in DNA: occurrence and metabolism; 2.1 Occurrence; 2.2 Repair; 3 Structural solutions for uracil recognition in diverse enzyme families; 3.1 Incorporation of uracil into the dUTPase active site; 3.2 Recognition of uracil in different families of uracil-DNA glycosylases; 4 Potential physiological roles for uracil in DNA; List of abbreviations; Acknowledgments.
List of abbreviationsReferences; Branched polymeric polypeptides with poly[Lys]; 1 Introduction; 2 Synthesis; 2.1 Synthesis and characterization of poly[Lys]; 2.2 Synthesis of poly[Lys(Xi-DL-Alam)] (XAK), i<1, m~3 polymeric polypeptides; 2.3 Synthesis of poly[Lys(DL-Serm-X)] (XSK), m~3 polymeric polypeptides; 2.4 Synthesis of poly[Lys(DL-Alam-Xi)] (AXK), i<1, m~3 polymeric polypeptides; 2.4.1 Poly[Lys(Xi)], (XiK) polypeptides, i<1; 2.4.2 Poly[Lys(DL-Alam-Xi)] (AXK) polypeptides i<1, m~3; 2.5 Poly[Lys-(X-DL-Ala3)n] (A3XK) and poly[Lys-(DL-Ala3-X)n] (XA3K) polymeric polypeptides.
2.6 Characterization of branched chain polypeptides with poly[Lys] backbone3 Conformation of branched polypeptides in solution; 3.1 The influence of the identity of amino acid X at the N-terminal of the branches; 3.2 The influence of the position of amino acid X in the branches; 4 Chemical structure -- biological properties; 4.1 Interaction with biomembrane models; 4.2 Biodegradation, in vitro cytotoxicity, immunoreactivity; 4.2.1 Cytotoxicity; 4.2.2 Immunoreactivity; 4.3 Biodistribution, cellular uptake; 4.3.1 Biodistribution; 4.3.2 Cellular uptake; 4.3.2.1 Uptake by tumour cells.
4.3.2.2 Uptake by macrophages5 Branched polypeptide bioconjugates; 5.1 Conjugates with reporter entity; 5.2 Conjugates with chemotherapeutic agent; 5.3 Conjugates with epitope oligopeptides or haptens; 5.3.1 Carrier effect on cell membrane stability and penetration; 5.3.2 Peptide conjugates as target antigens; 5.3.3 Peptide conjugates as immunogens; 6 Conclusion, perspectives; Abbreviations; Acknowledgments; References; Peptide-mediated pathogenesis of Alzheimer's disease; 1 Introduction; 2 Structure and function of wild-type tau protein; 2.1 Tau modifications underpinning AD symptoms.
Medienart: |
E-Book |
---|
Erscheinungsjahr: |
2019 © 2019 |
---|---|
Erschienen: |
Cambridge: Royal Society of Chemistry ; 2019 © 2019 |
Reihe: |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ryadnov, Maxim [HerausgeberIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
ISBN: |
---|
Themen: |
Amino acids |
---|
Umfang: |
1 Online-Ressource (154 Seiten) |
---|
doi: |
10.1039/9781788013857 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
1668128330 |
---|
LEADER | 01000cam a2200265 4500 | ||
---|---|---|---|
001 | 1668128330 | ||
003 | DE-627 | ||
005 | 20230819210549.0 | ||
007 | cr uuu---uuuuu | ||
008 | 190701s2019 xxk|||||o 00| ||eng c | ||
020 | |a 9781788013857 |c electronic bk. |9 978-1-78801-385-7 | ||
020 | |a 1788013859 |c electronic bk. |9 1-78801-385-9 | ||
020 | |a 9781788018661 |c ePub |9 978-1-78801-866-1 | ||
024 | 7 | |a 10.1039/9781788013857 |2 doi | |
035 | |a (DE-627)1668128330 | ||
035 | |a (DE-599)KXP1668128330 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
044 | |c XA-GB | ||
050 | 0 | |a QD431 | |
072 | 7 | |a SCI 007000 |2 bisacsh | |
245 | 1 | 2 | |a A specialist periodical report |b Amino acids, peptides and proteins |c editors: Maxim Ryadnov (National Physical Laboratory, UK), Ferenc Hudecz (Eötvös Lorand University, Hungary) |
264 | 1 | |a Cambridge |b Royal Society of Chemistry |c 2019 | |
264 | 4 | |c © 2019 | |
300 | |a 1 Online-Ressource (154 Seiten) | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
490 | 1 | |a Amino acids, peptides and proteins |v 43 | |
490 | 1 | |a Specialist periodical reports |v 43 | |
520 | |a Cover; Preface; Contents; A short guide to abbreviations and their use in peptide science; Search and destroy: versatile proteins offer unique structural solutions against uracil in DNA; 1 The widening chemical space of DNA; 2 Uracil in DNA: occurrence and metabolism; 2.1 Occurrence; 2.2 Repair; 3 Structural solutions for uracil recognition in diverse enzyme families; 3.1 Incorporation of uracil into the dUTPase active site; 3.2 Recognition of uracil in different families of uracil-DNA glycosylases; 4 Potential physiological roles for uracil in DNA; List of abbreviations; Acknowledgments | ||
520 | |a List of abbreviationsReferences; Branched polymeric polypeptides with poly[Lys]; 1 Introduction; 2 Synthesis; 2.1 Synthesis and characterization of poly[Lys]; 2.2 Synthesis of poly[Lys(Xi-DL-Alam)] (XAK), i<1, m~3 polymeric polypeptides; 2.3 Synthesis of poly[Lys(DL-Serm-X)] (XSK), m~3 polymeric polypeptides; 2.4 Synthesis of poly[Lys(DL-Alam-Xi)] (AXK), i<1, m~3 polymeric polypeptides; 2.4.1 Poly[Lys(Xi)], (XiK) polypeptides, i<1; 2.4.2 Poly[Lys(DL-Alam-Xi)] (AXK) polypeptides i<1, m~3; 2.5 Poly[Lys-(X-DL-Ala3)n] (A3XK) and poly[Lys-(DL-Ala3-X)n] (XA3K) polymeric polypeptides | ||
520 | |a 2.6 Characterization of branched chain polypeptides with poly[Lys] backbone3 Conformation of branched polypeptides in solution; 3.1 The influence of the identity of amino acid X at the N-terminal of the branches; 3.2 The influence of the position of amino acid X in the branches; 4 Chemical structure -- biological properties; 4.1 Interaction with biomembrane models; 4.2 Biodegradation, in vitro cytotoxicity, immunoreactivity; 4.2.1 Cytotoxicity; 4.2.2 Immunoreactivity; 4.3 Biodistribution, cellular uptake; 4.3.1 Biodistribution; 4.3.2 Cellular uptake; 4.3.2.1 Uptake by tumour cells | ||
520 | |a 4.3.2.2 Uptake by macrophages5 Branched polypeptide bioconjugates; 5.1 Conjugates with reporter entity; 5.2 Conjugates with chemotherapeutic agent; 5.3 Conjugates with epitope oligopeptides or haptens; 5.3.1 Carrier effect on cell membrane stability and penetration; 5.3.2 Peptide conjugates as target antigens; 5.3.3 Peptide conjugates as immunogens; 6 Conclusion, perspectives; Abbreviations; Acknowledgments; References; Peptide-mediated pathogenesis of Alzheimer's disease; 1 Introduction; 2 Structure and function of wild-type tau protein; 2.1 Tau modifications underpinning AD symptoms | ||
650 | 0 | |a Amino acids | |
650 | 0 | |a Peptides | |
650 | 0 | |a Proteins | |
650 | 4 | |a SCIENCE ; Life Sciences ; Biochemistry | |
650 | 4 | |a Amino acids | |
650 | 4 | |a Peptides | |
650 | 4 | |a Proteins | |
700 | 1 | |a Ryadnov, Maxim |e herausgeberin |4 edt | |
700 | 1 | |a Hudecz, Ferenc |e herausgeberin |4 edt | |
776 | 1 | |z 9781788013673 | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781788013673 |
830 | 0 | |a Amino acids, peptides and proteins |v 43 |9 43 |w (DE-627)362787301 |w (DE-576)304138894 |w (DE-600)2102321-9 |x 2050-9340 |7 ns | |
856 | 4 | 0 | |u http://dx.doi.org/10.1039/9781788013857 |m X:RSC |x Resolving-System |z lizenzpflichtig |3 Volltext |
912 | |a ZDB-1-RSEK |b 2019 | ||
912 | |a GBV_ILN_62 | ||
912 | |a ISIL_DE-28 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_70 | ||
912 | |a ISIL_DE-89 | ||
912 | |a GBV_ILN_120 | ||
912 | |a ISIL_DE-715 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_285 | ||
912 | |a ISIL_DE-517 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a ISIL_DE-25 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a ISIL_DE-291-415 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a ISIL_DE-90 | ||
912 | |a GBV_ILN_2027 | ||
912 | |a ISIL_DE-105 | ||
951 | |a BO | ||
953 | |2 045F |a 572.65 | ||
980 | |2 62 |1 01 |x 0028 |b 3711372279 |h OLR-RSEK |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Die Weitergabe an Dritte sowie systematisches Downloaden sind untersagt. |y z |z 08-07-20 | ||
980 | |2 70 |1 01 |x 0089 |b 3490286618 |h OLR-AL-RSE |k Campusweiter Zugriff (Universität Hannover).- Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y z |z 01-07-19 | ||
980 | |2 120 |1 01 |x 0715 |b 3520551365 |h OLR-zdb-1-rsek |k ww |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Die Weitergabe an Dritte sowie systematisches Downloaden sind untersagt. |y z |z 09-10-19 | ||
980 | |2 120 |1 02 |x 0715 |b 357710600X |c 00 |f --%%-- |d --%%-- |e g |j --%%-- |h alma |y z |z 20-01-20 | ||
980 | |2 170 |1 01 |x 3027 |b 3713527326 |h OLR-RSE |k Zugriff über DFG-Nationallizenz. Vervielfältigungen (z. B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y z |z 08-07-20 | ||
980 | |2 285 |1 01 |x 0517 |b 3522460499 |h OLR-RSEK |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y z |z 14-10-19 | ||
980 | |2 2003 |1 01 |x DE-25 |b 4017084958 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Elektronischer Volltext - Universitätslizenz. - Der Online-Zugriff auf die "RSC eBook Collection 2019" wird im Rahmen eines Nationalkonsortiums bereitgestellt und durch die Technische Informationsbibliothek Hannover (TIB) organisiert. |y l01 |z 08-12-21 | ||
980 | |2 2005 |1 05 |x DE-291-415 |b 4209698059 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |y l05 |z 11-11-22 | ||
980 | |2 2014 |1 01 |x DE-90 |b 3827879442 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 21-12-20 | ||
980 | |2 2027 |1 01 |x DE-105 |b 3906776662 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Campuslizenz |y l01 |z 13-04-21 | ||
981 | |2 62 |1 01 |x 0028 |r http://dx.doi.org/10.1039/9781788013857 | ||
981 | |2 70 |1 01 |x 0089 |r http://dx.doi.org/10.1039/9781788013857 | ||
981 | |2 120 |1 01 |x 0715 |r http://dx.doi.org/10.1039/9781788013857 | ||
981 | |2 120 |1 02 |x 0715 |r http://49gbv-uob-primo.hosted.exlibrisgroup.com/openurl/49GBV_UOB/UOB_services_page?u.ignore_date_coverage=true&rft.mms_id=991014931165803501 | ||
981 | |2 170 |1 01 |x 3027 |r http://dx.doi.org/10.1039/9781788013857 | ||
981 | |2 285 |1 01 |x 0517 |r http://dx.doi.org/10.1039/9781788013857 | ||
981 | |2 2003 |1 01 |x DE-25 |r https://www.redi-bw.de/start/unifr/RSC-ebooks/10.1039/9781788013857 | ||
981 | |2 2005 |1 05 |x DE-291-415 |r http://dx.doi.org/10.1039/9781788013857 | ||
981 | |2 2014 |1 01 |x DE-90 |y Zugang im Netz des KIT |r http://dx.doi.org/10.1039/9781788013857 | ||
982 | |2 2027 |1 01 |x DE-105 |8 00 |s s |a ebook | ||
995 | |2 62 |1 01 |x 0028 |a OLR-RSEK | ||
995 | |2 70 |1 01 |x 0089 |a OLR-AL-RSE | ||
995 | |2 70 |1 01 |x 0089 |a ACQ | ||
995 | |2 120 |1 01 |x 0715 |a OLR-zdb-1-rsek | ||
995 | |2 120 |1 02 |x 0715 |a alma | ||
995 | |2 170 |1 01 |x 3027 |a OLR-RSE | ||
995 | |2 285 |1 01 |x 0517 |a OLR-RSEK | ||
995 | |2 285 |1 01 |x 0517 |a ACQ |